Bill Text: NY A03575 | 2021-2022 | General Assembly | Introduced

---

Bill Title: Requires notification by a prescriber or pharmacist of the substitution of one generic drug product for another generic drug product; oral and written notification.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2022-01-05 - referred to higher education [A03575 Detail]

Download: New_York-2021-A03575-Introduced.html

---

                STATE OF NEW YORK
        ________________________________________________________________________

                                          3575

                               2021-2022 Regular Sessions

                   IN ASSEMBLY

                                    January 27, 2021
                                       ___________

        Introduced  by  M.  of  A.  CYMBROWITZ  -- read once and referred to the
          Committee on Higher Education

        AN ACT to amend the education law, in relation to  notification  of  the
          substitution of one generic drug product for another generic drug

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Subdivision 6 of section  6810  of  the  education  law  is
     2  amended by adding a new paragraph (b-1) to read as follows:
     3    (b-1) The prescriber or pharmacist shall inform the patient whether he
     4  or  she  has  prescribed or substituted a different generic drug product
     5  from the generic drug  product  the  patient  has  previously  received.
     6  Notification  required pursuant to this paragraph shall be provided both
     7  written and orally.
     8    § 2. This act shall take effect on the ninetieth day  after  it  shall
     9  have become a law.






         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD07031-01-1